ArticlePoultry science2026
Investigating the effects of thymol and cinnamaldehyde in T-2 toxin-treated hepatic cell cultures of chicken origin.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichothecenes are among the most significant mycotoxins, causing serious agricultural problems worldwide. One representative of these is T-2 toxin, which is often found in poultry feed. Due to its harmful effects, it is important to investigate substances that can counteract it. Such compounds include thymol and cinnamaldehyde, whose anti-inflammatory and antioxidant activities are well-documented. In this study, the effects of 24 h exposure to T-2 toxin (100 nM), thymol, and cinnamaldehyde (10 and 100 μg/mL in both cases) and their combinations with the toxin were examined in chicken-derived 3D liver cell cultures. Cellular viability was assessed by measuring the lactate dehydrogenase (LDH) activity. Inflammatory parameters were monitored by Luminex method, while the levels of oxidative and autophagy markers were determined by chicken-specific ELISA tests. Our results indicated that neither compound significantly affected cellular viability. T-2 toxin decreased interferon-γ (IFN-γ) and "Regulated on Activation, Normal T cell Expressed and Secreted" (RANTES), while increased macrophage colony-stimulating factor (M-CSF). Sole treatment of cinnamaldehyde reduced interleukin (IL)-10, IFN-γ, and RANTES, whereas thymol elevated IL-6 but lowered M-CSF and RANTES. In combination treatments, cinnamaldehyde further decreased IFN-γ, M-CSF, and RANTES, while thymol increased IL-6, IL-10, IFN-γ, and M-CSF relative to the T-2 toxin-treated cells. Thymol reduced nuclear factor (erythroid-derived 2)-like 2 (NRF-2), whereas cinnamaldehyde increased NRF-2 during combination treatment compared to the T-2 toxin-treated cells. Malondialdehyde (MDA) levels were lowered by cinnamaldehyde. Both compounds increased microtubule-associated protein 1 light chain 3 beta (LC3B) in combination treatments; however, cinnamaldehyde reduced P62 compared to the T-2 toxin-treated group. These results show that T-2 toxin exerted its negative effects by influencing inflammatory processes, but it was not cytotoxic. Thymol and cinnamaldehyde exhibited anti-inflammatory and, in some cases, even pro-inflammatory activity. In addition, both protective substances helped to initiate autophagy mechanisms in cells and influenced redox-related markers; cinnamaldehyde decreased MDA levels, while thymol modulated NRF-2 expression.
Indexed as
Identifiers
42772150What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.